Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Quick Stats
37.2
AI Score
SELL22.47
Volume Ratio
Next Earnings
10
+ve Days (30d)
19
-ve Days (30d)
QNCX Stock Summary
Last updated Jan 27, 2026
QNCX is currently trading at $0.17, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $0.161 to $4.5499.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 53.524, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.004, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates QNCX at 37.2/100 with a SELL recommendation.
QNCX (Quince Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 27, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 53.524 |
| CMF (20) | 0.004 |
| ROC (10) | 12.203 |
| ADX (14) | 19.119 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.003 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -35.345 |
| MFI (14) | 70.053 |
QNCX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
QNCX Price vs Max Options Open Interest
QNCX Max Change In Options Open Interest
QNCX Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QNCX Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QNCX Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QNCX Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Quince Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
QNCX Moving Averages Analysis
QNCX (Quince Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
QNCX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 9.5 million |
| Earnings/Share ($) | -1.2 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.0975 |
| EPS Estimate Next Year ($) | -0.6975 |
| WallStreet Target Price ($) | 7.6667 |
| Most Recent Quarter |